Abstract

In approaches to the treatment of infectious lesions of the myocardium, contradictions remain. Scientific studies evaluating the effectiveness of various drugs in infectious myocarditis that developed against the background of acute respiratory infections are few and contradictory. Metabolic agents for various pathologies of the myocardium, according to some authors, are undoubtedly necessary, but others consider their appointment unreasonable. Almost 80% of patients with various acute infectious diseases reveal certain changes in cardiovascular activity. Most of them represent a natural functional reaction of the body to the action of the pathogen and completely disappear as a result of the treatment of the underlying pathology.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.